18.05.2013 Views

Professor Atiene Solomon Sagay - University of Jos Institutional ...

Professor Atiene Solomon Sagay - University of Jos Institutional ...

Professor Atiene Solomon Sagay - University of Jos Institutional ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

FACING THE CHALLENGES OF MOTHERHOOD; THAT THESE LITTLE<br />

ONES MAY LIVE<br />

Text <strong>of</strong> Inaugural Lecture<br />

By<br />

<strong>Pr<strong>of</strong>essor</strong> <strong>Atiene</strong> <strong>Solomon</strong> <strong>Sagay</strong><br />

BSc, MBChB, FWACS, FICS, FRCOG (Lond)<br />

<strong>Pr<strong>of</strong>essor</strong> <strong>of</strong> Obstetrics and Gynaecology<br />

Hon. Consultant Obstetrician and Gynaecologist<br />

<strong>University</strong> <strong>of</strong> <strong>Jos</strong> / <strong>Jos</strong> <strong>University</strong> Teaching Hospital<br />

PMB 2084, <strong>Jos</strong>, Nigeria<br />

Mobile: 08034519740 e-mail: atsagay58@yahoo.com<br />

The natural desire <strong>of</strong> a woman <strong>of</strong> any culture to bear a biological child <strong>of</strong> her own is usually<br />

strong. It is the expression <strong>of</strong> a deep and compelling innate call to motherhood. The<br />

processes <strong>of</strong> pregnancy, child birth and child rearing are unique life-transforming motherhood<br />

experiences that a woman looks forward to as she comes <strong>of</strong> age. I intend to explore these<br />

processes and discuss the numerous challenges women face in Nigeria, by examining five<br />

basic questions:<br />

1. What if a woman fails to conceive or keep pregnancies?<br />

2. What if a pregnancy is unintended and unwanted?<br />

3. How hazardous can pregnancy and childbirth be?<br />

4. Are there any concerns about survival <strong>of</strong> the newborn?<br />

5. Are there emerging challenges to motherhood in the HIV era?<br />

1. What if a woman fails to conceive or fails to keep pregnancies?<br />

Definition <strong>of</strong> infertility<br />

Infertility primarily refers to the biological inability <strong>of</strong> a person to contribute to conception.<br />

For a couple, infertility refers to the inability to achieve conception after 12 months <strong>of</strong><br />

unprotected sex. Infertility may also refer to the condition <strong>of</strong> a woman who is unable to carry<br />

a pregnancy to a state <strong>of</strong> viability.<br />

There are many biological causes <strong>of</strong> infertility and in general, it is estimated that in 30% <strong>of</strong><br />

infertile couples, the problem is with the woman, in another 30% the problem is only with the<br />

man and in a further 30%, the defects are found in both parties while in the final 10% <strong>of</strong><br />

1


couples, no abnormalities are found (unexplained infertility). It is estimated that one out <strong>of</strong><br />

every 6 couples in Nigeria are infertile.<br />

We evaluated 1000 consecutive infertile women in <strong>Jos</strong>, Nigeria and found that 410 (41%) had<br />

never ever conceived (primary infertility) while 590 (59%) have had at least one prior<br />

pregnancy (secondary infertility) (<strong>Sagay</strong> et al 1998). More than 4 out <strong>of</strong> every 10 (42.3%) <strong>of</strong><br />

these women had blocked tubes on both sides (bilateral tubal occlusion). Of the 548 (54.8%)<br />

<strong>of</strong> these infertile women who were found to have pelvic adhesive disease, two-thirds (66%)<br />

had moderate to severe pelvic adhesions for which reconstructive surgical outcome is poor.<br />

What this means is that a large proportion (about 40%) <strong>of</strong> infertile women in Nigeria have<br />

badly damaged reproductive organs for which assisted conception in the form <strong>of</strong> in-vitro<br />

fertilization and embryo transfer (a.k.a. test tube baby) is required. The prevailing cost <strong>of</strong> this<br />

procedure in Nigeria (about 700,000 Naira) is however out <strong>of</strong> the reach <strong>of</strong> most infertile<br />

couples in this country.<br />

On the male side, we studied the semen quality <strong>of</strong> male partners <strong>of</strong> infertile couples in <strong>Jos</strong><br />

(Imade et al. 2000). In all, we analysed the semen <strong>of</strong> 428 male partners <strong>of</strong> infertile women<br />

using the World Health Organisation (WHO) guidelines. The findings revealed that 124<br />

(29%) <strong>of</strong> the men had normal semen parameters (normozoospermia) while 304 (71%) had<br />

abnormal semen quality. The semen abnormalities comprised; 39 (9.1%) with complete<br />

absence <strong>of</strong> spermatozoa (azoospermia), 89 (21%) with significantly reduced population <strong>of</strong><br />

spermatozoa (oligozoospermia), 22 (5.1%) with poor movement (asthenozoospemia) and 18<br />

(4.2%) with abnormal physical forms (teratozoospermia). Another 134 (31.5%) men had<br />

various combinations <strong>of</strong> these seminal abnormalities. The findings suggested that the male<br />

partner is a significant contributor to the problem <strong>of</strong> infertility in <strong>Jos</strong>.<br />

Psycho-social consequences <strong>of</strong> infertility<br />

A Yoruba adage says “Omo laso”, meaning children are clothes, without them you are<br />

naked. Infertile couples feel insecure and vulnerable to societal stigmatization.<br />

The psycho-social challenge faced by infertile women is age-long. Evidence from<br />

biblical time shows that women have contemplated suicide as a response to their<br />

continued barrenness. Rachael, wife <strong>of</strong> Jacob considered live worthless without a<br />

child <strong>of</strong> her own: [Gen 30:1 And when Rachel saw that she bore Jacob no children,<br />

Rachel envied her sister. And she said to Jacob, Give me sons, or else I will die].<br />

Anthropologists who worked in different communities in the South-south region <strong>of</strong> Nigeria<br />

concluded that; "the necessity for a woman to have a child remains basic in this region.<br />

Motherhood continues to define an individual woman's treatment in her community, her selfrespect,<br />

and her understanding <strong>of</strong> womanhood" (Hollos et al 2009).<br />

In focus group discussions on the social meaning <strong>of</strong> infertility in south-western Nigeria,<br />

(Okon<strong>of</strong>ua et al.1997) reported the following community perceptions;<br />

that infertility is not <strong>of</strong>ten discussed, and if at all, must be discussed carefully and<br />

privately. This was largely to avoid embarrassing those who were infertile.<br />

that an infertile person would be extremely sensitive to any discussion about children<br />

or pregnancy, and would assume that even comments in casual conversations were<br />

2


meant to make fun <strong>of</strong> them. This is in the context <strong>of</strong> the belief that a person without<br />

children has failed in a fundamental way.<br />

that women are most <strong>of</strong>ten blamed for the infertility problem. There are many who<br />

believe that a man cannot be infertile, as fertility and potency are <strong>of</strong>ten thought to be<br />

synonymous.<br />

that a common consequence <strong>of</strong> a couple's infertility is the expulsion <strong>of</strong> the woman<br />

from the husband's house, with or without divorce. People most commonly responded<br />

by saying the husband would ‗send her packing‘. Thus, having children is clearly<br />

more important than loyalty to one's spouse, which is evidenced by the common<br />

practice <strong>of</strong> divorce because <strong>of</strong> childlessness, or forceful ejection <strong>of</strong> the wife from the<br />

husband's home, either by the husband himself or by his family.<br />

that infertile women are <strong>of</strong>ten excluded from inheriting property, from decisionmaking<br />

in the family, and from any type <strong>of</strong> financial or social security.<br />

that it is common for people to avoid those women known to be infertile, and women<br />

<strong>of</strong>ten tell their children to avoid these women, either because they think the women<br />

might harm their children because <strong>of</strong> their bitterness, or because they might not know<br />

how to look after other children properly.<br />

that there are strong beliefs that some infertile women were witches, had given birth to<br />

children in another world, and taken a secret vow never to bear children on earth. This<br />

belief justifies the attempt to ostracize these women, and to expel them from their<br />

households.<br />

that <strong>of</strong>ten, any subsequent misfortune <strong>of</strong> the woman or family which would ordinarily<br />

be taken in isolation may instead be attributed to her infertility and/or witchcraft.<br />

A woman‘s ability to make decisions within the family, and her ability to inherit her<br />

husband‘s property are almost exclusively dependent upon fertility.<br />

Clearly, infertile women in the Nigerian socio-cultural setting face tremendous challenges<br />

and perhaps as a consequence, there is a high prevalence <strong>of</strong> psychological problems among<br />

infertile women.<br />

In a Nigerian study, nearly one-third <strong>of</strong> infertile women were found to have diagnosable<br />

psychopathology, mainly depressive episode and generalized anxiety disorder. Compared<br />

with the control group, the infertile women experienced poorer marital relationships and<br />

polygamy was found to have a close association with psychopathology. (Aghanwa et al.1999)<br />

A recent article in the Canadian Medical Association Journal reported the finding that<br />

motherhood appears to protect against suicide, with increasing numbers <strong>of</strong> children<br />

associated with decreasing rates <strong>of</strong> death from suicide. Having children may protect against<br />

suicide because children may increase a mother's feelings <strong>of</strong> self-worth. Children may also<br />

provide emotional and material support to a mother and provide her with a positive social<br />

role. As well, motherhood may enhance social networks and social support.<br />

Recurrent pregnancy losses (Habitual abortion)<br />

There is no experience more difficult than having to go through a miscarriage during<br />

pregnancy. Miscarriage is not only physically taxing, but very emotionally challenging, as<br />

well. Yet, pregnancy loss can be even harder to deal with when it occurs time and time again.<br />

3


Known as recurrent pregnancy loss, repeated miscarriage is difficult for both partners<br />

involved. It can also make fertility treatments particularly challenging.<br />

Recurrent pregnancy loss occurs when a women loses three or more consecutive pregnancies.<br />

The majority <strong>of</strong> recurrent pregnancy losses occur early in pregnancy, typically during the first<br />

half <strong>of</strong> pregnancy. Recurrent pregnancy loss is very difficult for couples to experience,<br />

especially because a cause for these miscarriages is <strong>of</strong>ten never determined. Nevertheless, by<br />

undergoing specific fertility testing and treatment, there is hope that couples who have<br />

experienced multiple miscarriages will go on to welcome a healthy child <strong>of</strong> their own.<br />

Fortunately, recurrent pregnancy loss is relatively rare as fewer than 3% <strong>of</strong> couples go<br />

through more than three miscarriages in a row. It is more likely to occur in older women who<br />

have had two previous pregnancy losses and engaged in certain life-styles such as smoking,<br />

heavy drinking and drug use.<br />

Unfortunately, it is difficult to pinpoint the underlying cause <strong>of</strong> pregnancy loss. In fact, more<br />

than 50% <strong>of</strong> couples that experience the problem never find out what is responsible for their<br />

miscarriages. However, there are a number <strong>of</strong> conditions that do underlie some cases <strong>of</strong><br />

recurrent miscarriage. They include genetic factors, structural uterine problems, hormonal<br />

imbalance and blood clotting disorders.<br />

2. What if a pregnancy is unintended and unwanted?<br />

Each year, thousands <strong>of</strong> Nigerian women have unintended pregnancies that end in illegal<br />

abortion. Many <strong>of</strong> such procedures occur under unsafe conditions, contributing to maternal<br />

morbidity and mortality. To highlight this challenge, permit me to share an experience<br />

during my residency training.<br />

It was about 9.00pm on a cold April night in mid-1980s, I was on my first call duty as a<br />

resident doctor in the <strong>Jos</strong> university teaching hospital, <strong>Jos</strong>, and I was asked to review and<br />

admit a young lady who was said to be having vaginal bleeding. She was a university<br />

undergraduate. On the couch, I found a pretty, young lady with a stylish hair do, who was<br />

very pale, cold, motionless and stiff. My examination confirmed that she was dead. I tried to<br />

conceal my horror and politely told the porter to take her back to the casualty <strong>of</strong>ficer and<br />

demonstrated to him that she was brought in dead and could not be admitted to the<br />

gynaecology ward. The brief history suggested that she had a termination <strong>of</strong> pregnancy<br />

somewhere in town that evening. That night, as I reflected on the scene, I realised I had just<br />

witnessed an avoidable maternal death. This experience remained on my mind all through my<br />

residency training and served as a constant reminder <strong>of</strong> how hazardous being a woman in<br />

Nigeria can be.<br />

Abortion in Nigeria is illegal except to save a woman‘s life. Of the estimated 6.8 million<br />

pregnancies that occur annually in Nigeria, one in five is unplanned and half <strong>of</strong> these end in<br />

an induced abortion. (Guttmacher Institute 2008) Abortion is therefore common in Nigeria<br />

and most procedures are performed under unsafe, clandestine conditions. In 1996, an<br />

estimated 610,000 abortions occurred (25 per 1000 women <strong>of</strong> childbearing age), <strong>of</strong> which<br />

142,000 resulted in complications severe enough to require hospitalization. The number <strong>of</strong><br />

abortions is estimated to have risen to 760,000 in 2006 (Bankole et al. 2006). Unsafe<br />

abortions are a major reason Nigeria‘s maternal mortality ratio – 1,100 deaths per 100,000<br />

live births- is one <strong>of</strong> the highest in the world (WHO 2007). According to conservative<br />

4


estimates, more than 3,000 women die annually in Nigeria as a result <strong>of</strong> unsafe abortion<br />

(Henshaw SK et al 2008).<br />

In countries like Nigeria with low contraceptive uptake, a high rate <strong>of</strong> unintended pregnancies<br />

and poor access to safe maternal healthcare services, each pregnancy puts a woman‘s life at<br />

considerable risk. Women in Africa experience a 1 in 26 (1 in 18 in Nigeria) lifetime risk <strong>of</strong><br />

dying from pregnancy- or childbirth-related complications. This is compared to a 1 in 7,300<br />

lifetime risk for their counterparts in developed countries. Among a total <strong>of</strong> 171 countries for<br />

which estimates were made, the adult lifetime risk <strong>of</strong> maternal death (the probability that a<br />

15-year-old female will die eventually from a maternal cause) was highest in Nigeria‘s<br />

northern neighbour Niger (1 in 7 ), in stark contrast to Ireland, which had the lowest lifetime<br />

risk <strong>of</strong> 1 in 48,000 (WHO 2005).<br />

The likelihood <strong>of</strong> complications during pregnancy and delivery is increased in the face <strong>of</strong>: too<br />

many pregnancies, too short an interval between pregnancies, having a pregnancy too early in<br />

life, or having a pregnancy too late in life.<br />

These conditions can negatively affect a woman‘s long-term health by depleting her<br />

nutritional and overall health status— contributing to anaemia, fatigue, increased blood<br />

pressure and decreased immunity to diseases such as malaria and reproductive tract<br />

infections. These factors can also increase the risk <strong>of</strong> excessive blood loss immediately after<br />

delivery, birth injury, miscarriage, or stillbirth.<br />

Clearly, maternal and neonatal deaths can be prevented by (1) limiting the number <strong>of</strong><br />

pregnancies each woman experiences during her lifetime and (2) improving access to<br />

reproductive and maternal healthcare—particularly antenatal care, skilled attendance at<br />

delivery, emergency obstetric care, postpartum care, and post-abortion care. Making family<br />

planning a component <strong>of</strong> safe motherhood programs, should help women limit their overall<br />

fertility and reduce the number <strong>of</strong> times they are at risk for maternal death; space births,<br />

thereby allowing their bodies to recover from previous pregnancies; and time their<br />

pregnancies. These services must also be accessible to youths.<br />

Over the last 25 years, the <strong>Jos</strong> <strong>University</strong> Teaching Hospital (JUTH), <strong>Jos</strong> has <strong>of</strong>fered family<br />

planning services to all comers and has built tremendous human and institutional capacity. In<br />

the mid 1980s, the department <strong>of</strong> obstetrics and gynaecology at JUTH established a voluntary<br />

surgical contraception unit principally for the provision <strong>of</strong> female sterilization services. The<br />

unit remains one <strong>of</strong> the most active in the country and a number <strong>of</strong> reports have been<br />

published (Otubu et al 1990, Aisien et al 2001, Aisien et al 2002). With the advent <strong>of</strong> novel<br />

contraceptive implants in the 1980s and 1990s, and the instant popularity <strong>of</strong> this non-sex<br />

related, long-term, reversible contraceptive method among our clients, a number <strong>of</strong> studies on<br />

the safety pr<strong>of</strong>ile among Nigerian women were undertaken in the department.<br />

The effect <strong>of</strong> Norplant on serum lipids and lipoproteins (agents that are incriminated in heart<br />

and vascular diseases) was studied by Otubu et al. (1993) Serum triglycerides and total<br />

cholesterol were reduced. High density lipoprotein-cholesterol (HDL-chol) exhibited<br />

statistically significant reduction and low density lipoprotein-cholesterol (LDL-chol) was<br />

significantly elevated at 6 months. The changes in lipid pr<strong>of</strong>ile with regards to cardiovascular<br />

morbidity were mixed. Norplant use was not associated with adverse lipid pr<strong>of</strong>ile.<br />

5


We studied the effects <strong>of</strong> Norplant® on the electrical activity <strong>of</strong> the heart and showed a<br />

tendency to significant prolongation <strong>of</strong> ECG intervals (a tendency to cause heart blocks)<br />

(<strong>Sagay</strong> et al 2002, Okeahialam et al 2004). Although these ECG changes appeared<br />

innocuous, we advised that patients with pre-morbid cardiac conditions should use alternative<br />

contraceptives until these effects are clearly elucidated. Norplant® did not show any<br />

adverse effects on diastolic and systolic blood pressures over time.<br />

Of additional note are the findings that Norplant use is associated with the depletion <strong>of</strong><br />

platelet counts (Aisien et al 2002), weight gain after 2 years <strong>of</strong> use (<strong>Sagay</strong> et al 2008 ) and<br />

mild but reversible impairment <strong>of</strong> glucose metabolism (<strong>Sagay</strong> et al 2000).<br />

The effect <strong>of</strong> Norplant® use on the bone quality <strong>of</strong> Nigerian women using quantitative<br />

ultrasound measurements and serum markers <strong>of</strong> bone turnover (VanderJagt et al 2005)<br />

We used calcaneal ultrasound to compare the bone quality <strong>of</strong> Nigerian women between 25<br />

and 50 years <strong>of</strong> age who had Norplant implants for 1-4 years to that <strong>of</strong> women who were not<br />

using any form <strong>of</strong> hormonal contraceptive. The mean stiffness index <strong>of</strong> women who had<br />

Norplant implants for as long as 4 years was not significantly different from that <strong>of</strong> controls.<br />

However, serum markers <strong>of</strong> bone turnover were significantly decreased in women with<br />

Norplant implants compared to age-matched controls. Serum bone-specific alkaline<br />

phosphatase was significantly decreased in subjects with Norplant implants for 1 year and<br />

serum N-Telopeptidase was significantly decreased in subjects with implants for 3 years. We<br />

conclude that although levonorgestrel contraceptive decreased overall bone turnover, it had<br />

no deleterious effect on the bone quality <strong>of</strong> women using Norplant implants for up to 4 years.<br />

(VanderJagt et al 2005).<br />

Overall, Norplant® use in our women was not associated with any serious adverse effects.<br />

Contraceptive implants have remained popular in our family planning clinics today.<br />

3. How hazardous can pregnancy and childbirth be?<br />

If a mother dies, the infant has little chance <strong>of</strong> survival<br />

Maternal mortality: This is defined as the death <strong>of</strong> a woman while pregnant or within 42 days<br />

<strong>of</strong> termination <strong>of</strong> pregnancy, irrespective <strong>of</strong> the duration and the site <strong>of</strong> the pregnancy, from any<br />

cause related to or aggravated by the pregnancy or its management, but not from accidental or<br />

incidental causes.<br />

Worldwide, every minute a woman dies from pregnancy-related complications.<br />

Maternal mortality ratio: The number <strong>of</strong> maternal deaths per 100,000 live births.<br />

The maternal mortality ratio in Nigeria is 545 deaths per 100,000 live births. (NDHS 2010)<br />

Maternal morbidity: Refers to serious disease, disability or physical damage such as fistula,<br />

caused by pregnancy-related complications.<br />

6


For every woman who dies, 15 to 30 live but suffer chronic disabilities, the worst <strong>of</strong><br />

which is obstetric fistula.<br />

The vast majority <strong>of</strong> women in Nigeria who desire to conceive will conceive within a year and<br />

the pregnancies will develop normally and end with an uneventful vaginal delivery. However, a<br />

number <strong>of</strong> factors conspire to endanger maternal lives in this country. Permit me to mention<br />

these factors without much elaboration.<br />

Risk factors for maternal mortality in Nigeria<br />

1. Susceptible social context:<br />

The social context that contributes to high mortality and morbidity includes a culture<br />

that undervalues women; control <strong>of</strong> women by men; seclusion <strong>of</strong> wives that limits<br />

access to medical care; female illiteracy; early marriage and pregnancy; high rates <strong>of</strong><br />

obstructed labor; directly harmful traditional medical beliefs and practices; inadequate<br />

facilities to treat obstetric emergencies; a declining economy; and a corrupt, inefficient<br />

political culture (Wall LL 1998), additionally, restrictive abortion laws and a<br />

dysfunctional criminal justice system.<br />

2. Non- booking for antenatal care.<br />

3. Ineffective antenatal care.<br />

4. Delivery without skilled attendant.<br />

5. Delays in getting pr<strong>of</strong>essional medical service.<br />

a. Delay by patient in seeking medical care [Individual patient and community].<br />

b. Delay in arriving at a medical facility [communication and transportation<br />

system].<br />

c. Delay in the provision <strong>of</strong> appropriate care at the medical facility [health<br />

personnel and institutional].<br />

Globally, each year there are at least half a million maternal deaths, 3.2 million stillborn<br />

babies, 4 million neonatal deaths. The majority <strong>of</strong> these deaths are avoidable. A total <strong>of</strong> 11–<br />

17% <strong>of</strong> maternal deaths occur during childbirth itself; 50–71% occur in the post-partum<br />

period. The time spent in labour and giving birth, the critical moments when a joyful event<br />

can suddenly turn into an unforeseen crisis, needs more attention, as does the <strong>of</strong>ten-neglected<br />

post-partum period. These periods account not only for the high burden <strong>of</strong> post-partum<br />

maternal deaths, but also for the associated large number <strong>of</strong> stillbirths and early newborn<br />

deaths.<br />

A total <strong>of</strong> 98% <strong>of</strong> stillbirths and newborn deaths occur in low- and middle-income countries:<br />

obstetric complications, particularly in labour, are responsible for perhaps 58% <strong>of</strong> them. The<br />

care that can reduce maternal deaths and improve women‘s health is also crucial for<br />

newborns‘ survival and health.<br />

7


In developed countries, the advent <strong>of</strong> modern obstetric care in the late 1930s gradually moved<br />

the process <strong>of</strong> childbirth from home to institutional settings, with post-partum follow-up and<br />

care by a skilled health-care provider. In most developing countries including Nigeria, the<br />

majority <strong>of</strong> women deliver at home without skilled health-care providers. The Nigerian<br />

Demographic and Health Survey 2008 reported that in the North-central zone <strong>of</strong> Nigeria,<br />

65% <strong>of</strong> pregnant women receive antenatal care while only 41% deliver in health facility<br />

(NDHS 2010). In Plateau State, Nigeria in 2004, a total <strong>of</strong> 71,655 women attended at least<br />

one antenatal visit but only 22,640 delivered in health facilities, indicating that over twothirds<br />

<strong>of</strong> women who attend antenatal care still deliver at home. Little wonder that we<br />

reported a maternal mortality ratio <strong>of</strong> 740 maternal deaths / 100,000 births (Ujah et.al 2005).<br />

The challenges to be met are not new technologies or new knowledge about effective<br />

interventions, because we mostly know what needs to be done to save the lives <strong>of</strong> mothers<br />

and newborns. The real challenges are how to deliver services and scale up interventions,<br />

particularly to those who are vulnerable, hard to reach, marginalized and excluded. Effective<br />

health interventions exist for mothers and babies such as post-abortal care, emergency<br />

obstetrics care, immunization, nutrition counselling and reproductive health services.<br />

However, none will work if political will is absent where it matters most: at national, state<br />

and local government levels.<br />

A key constraint limiting progress is the gap between what is needed and what exists in terms<br />

<strong>of</strong> skills and geographical availability <strong>of</strong> human resources at local, state and national levels.<br />

The Midwifery service scheme which is being implemented by the federal government<br />

through the national primary health care development agency (NPHCDA) is a commendable<br />

step. The table below highlights the nursing personnel gaps in PHCs in all 17 local<br />

government areas <strong>of</strong> Plateau State (Table 1).<br />

Other challenges are how to address deteriorating infrastructures; how to maintain stocks <strong>of</strong><br />

drugs, supplies and equipment in the face <strong>of</strong> increased demand; lack <strong>of</strong> transport; ineffective<br />

referral to and inadequate availability <strong>of</strong> 24-hour quality services – particularly emergency<br />

obstetric care services – and weak management systems. We need to challenge our policymakers<br />

and unit heads to refocus on the development <strong>of</strong> viable organizational strategies for<br />

monitoring and evaluation that ensure a continuum <strong>of</strong> care and account for every birth and<br />

death.<br />

South Africa is one <strong>of</strong> the few developing countries with a national confidential inquiry into<br />

maternal deaths. 164 health facilities obtain audit data for stillbirths and neonatal deaths, and<br />

a new audit network does so for child deaths. Three separate reports have been published,<br />

providing valuable information about avoidable causes <strong>of</strong> death for mothers, babies, and<br />

children. The leaders <strong>of</strong> these three reports have united to prioritise actions to save the lives<br />

<strong>of</strong> South Africa's mothers, babies, and children (Bradshaw et al 2008).<br />

Nigeria should establish a national confidential inquiry into maternal deaths and mandatorily<br />

obtain audit data for stillbirth, neonatal and child deaths. Although Edo and Ondo States have<br />

already promulgated the enabling laws, I advocate a national buy in and leadership at the<br />

national level.<br />

8


Table 1: Nursing personnel gaps in PHCs in Plateau State (2009)<br />

As we plan to obtain these relevant data, clear framework and procedures for data use to<br />

improve national vital health statistics should be developed. Audit is powerful, but only if the<br />

data lead to action.<br />

Nigeria‘s most recent maternal mortality ratio <strong>of</strong> 545deaths/100,000 live births gives the<br />

impression that things have substantially improved.<br />

Before we leave with such impression, let me outline the findings <strong>of</strong> two recent study by<br />

Mairiga and Saleh (2009) and Kullima et al (2009) that reported maternal mortality in<br />

Bauchi Specialist Hospital, Bauchi, Bauchi State and Federal Medical Centre, Nguru, Yobe<br />

State.<br />

Bauchi, Bauchi State:<br />

Maternal Mortality Ratio (MMR) for the period under review was 1,732 per 100, 000 live<br />

births. Six hundred and twenty one (621) <strong>of</strong> the deaths (81.0%) occurred in 12,067 unbooked<br />

deliveries giving a maternal mortality ratio <strong>of</strong> 5,146 per 100,000 for unbooked mothers (11fold<br />

increase in maternal mortality over booked mothers). The annual MMR was highest for<br />

the year 2006 (2,586 per 100,000).<br />

Nguru, Yobe State:<br />

At Federal Medical Centre, Nguru, a total <strong>of</strong> 112 maternal deaths were recorded in 3,931<br />

deliveries giving a MMR <strong>of</strong> 2849/100,000 deliveries in the 5-year period studied. The highest<br />

MMR <strong>of</strong> 6234/100,000 was observed in 2003, with remarkable decline to 1837/100,000 in<br />

2007. Eclampsia was the leading cause, accounting for 46.4% <strong>of</strong> the maternal deaths,<br />

followed by sepsis and postpartum haemorrhage (PPH) contributing 17% and 14.3%,<br />

9


espectively. Lack <strong>of</strong> antenatal care (Unbooked status) and illiteracy were the significant<br />

determinants <strong>of</strong> maternal mortality.<br />

When we compare these maternal mortality figures with 3/100,000 deliveries in Sweden,<br />

4/100,000 deliveries in Spain, 5/100,000 deliveries in Switzerland and 8/100,000 deliveries in<br />

the United Kingdom (WHO 2005), they become terribly disturbing. These staggering<br />

maternal mortality figures are a reflection <strong>of</strong> the premium placed on the lives <strong>of</strong> women in<br />

this country. These women do not die <strong>of</strong> diseases that can’t be treated or complications that<br />

can’t be prevented. To quote Mahmoud Fathalla, former president <strong>of</strong> the International<br />

Federation <strong>of</strong> Obstetricians and Gynecologists, “they die because societies have yet to determine<br />

that their lives are worth saving”. Sadly, if a woman does not survive, her child has little<br />

chance <strong>of</strong> survival.<br />

Vesico-Vaginal Fistula (VVF)<br />

For every woman who dies at childbirth, 15 to 30 live but suffer chronic disabilities, the<br />

worst <strong>of</strong> which is obstetric fistula. Each year some 50,000-100,000 women sustain an<br />

obstetric fistula in the act <strong>of</strong> trying to bring forth new life. Fistula is a preventable and<br />

treatable condition, one that no woman should have to endure. Yet more than two million<br />

women remain untreated in developing countries.<br />

Obstetric fistula is the most devastating <strong>of</strong> all pregnancy-related disabilities. It usually occurs<br />

when a young, poor woman has an obstructed labour and cannot get a Caesarean section<br />

when needed. The obstruction can occur because the woman‘s pelvis is too small, the baby‘s<br />

head is too big, or the baby is badly positioned. The woman can be in labour for three days or<br />

more without medical help. The baby usually dies. If the mother survives, she is left with<br />

extensive tissue damage to her birth canal that renders her incontinent.<br />

The results are life shattering. The woman is unable to stay dry and the smell <strong>of</strong> urine or<br />

faeces is constant and humiliating. Nerve damage to her legs can also make it difficult to<br />

walk. Rather than being comforted for the loss <strong>of</strong> her child, she is <strong>of</strong>ten rejected by her<br />

husband, shunned by her community and blamed for her condition. Women who remain<br />

untreated not only face a life <strong>of</strong> shame and isolation, but may also face a slow, premature<br />

death from infection and kidney failure. While some women receive support from their<br />

families, others are forced to beg or turn to sex work for a living.<br />

During obstructed labour, the prolonged pressure <strong>of</strong> the baby‘s head against the mother‘s<br />

bony pelvis cuts <strong>of</strong>f the blood supply to the s<strong>of</strong>t tissues <strong>of</strong> her vagina, bladder and rectum that<br />

are trapped between the harder (bony) structures. The injured s<strong>of</strong>t tissue soon rots away,<br />

leaving a hole, or fistula. If the hole is between the woman‘s vagina and bladder, she loses<br />

control over her urination, and if it is between her vagina and rectum, she loses control <strong>of</strong> her<br />

bowels. Reconstructive surgery can mend this injury, but most women are either unaware that<br />

treatment is available or cannot access or afford it. Fistula surgical repair has up to 90 per<br />

cent success rates and costs between N20, 000 to N60, 000. In supported VVF repair and<br />

rehabilitation centres, most services are provided free <strong>of</strong> charge. ECWA Evangel Hospital is<br />

one such centre in <strong>Jos</strong>, Nigeria.<br />

In the words <strong>of</strong> DR. ANDREW ARKUTU ―An obstetric fistula is more than a hole. For those<br />

afflicted, it is a comprehensive social and psychological disaster, resulting from a dramatic<br />

failure in obstetric care.‖<br />

10


The tragedy <strong>of</strong> an obstetric fistula is that it touches a young girl at the very essence <strong>of</strong> her<br />

being - her childbearing capabilities. It touches her when she is too young to understand what<br />

has happened. . . If not operated on or helped, recurrent urinary tract infections can lead to<br />

kidney problems and eventual renal failure and death. So, though the girl with obstetric<br />

fistula is a survivor <strong>of</strong> maternal mortality statistics in the first light, is she really, if she dies<br />

later, unwanted, humiliated and lonely in some remote village hut?<br />

Clinical Audit <strong>of</strong> Primary Health Centres in <strong>Jos</strong>, Nigeria<br />

In 1978 at Alma Ata, the United Nations adopted primary health care, as a global strategy for<br />

promoting health for all by the year 2000, a policy that was adopted by Nigeria in 1988. The<br />

emphasis was on preventive rather than curative medicine. The federal ministry <strong>of</strong> health<br />

through the states and local governments established Primary Health Centres (PHCs) in all<br />

local government areas in this country. One <strong>of</strong> the aims was to improve access to affordable<br />

antenatal care for pregnant women in order to achieve a substantial reduction in maternal and<br />

perinatal deaths. Despite these efforts by government, maternal and perinatal death rates did<br />

not decline. Pregnant women are frequently referred late from PHCs to tertiary institutions,<br />

resulting in adverse obstetric outcomes (Kuti et al 2001). The high proportion <strong>of</strong> avoidable<br />

maternal deaths in the maternity unit <strong>of</strong> JUTH resulting from late referrals from PHCs around<br />

<strong>Jos</strong> prompted us to conduct a clinical audit <strong>of</strong> these centres (<strong>Sagay</strong> et al 2005).<br />

The study evaluated the quality <strong>of</strong> antenatal care services in 12 randomly selected PHCs in<br />

the <strong>Jos</strong>/Bukuru metropolis. The findings indicated that:<br />

High risk obstetric cases (previous caesarean section, hypertension, and previous post<br />

partum haemorrhage) were being booked and seen at the PHCs.<br />

Over two-thirds <strong>of</strong> pregnant women receiving antenatal care at PHCs did not have<br />

blood pressure surveillance through pregnancy.<br />

Routine malaria prophylaxis during pregnancy was not given in any <strong>of</strong> the PHCs.<br />

About two-thirds <strong>of</strong> pregnant women receiving antenatal care did not have any<br />

documented attempt to ascertain the gestational age.<br />

No pregnant woman was screened for sickle cell disease (sickling test or genotype).<br />

The principal examination that almost all patients had was weighing which has been<br />

shown to have little impact on obstetric outcome.<br />

Undoubtedly, we considered antenatal care provided at the PHCs in the <strong>Jos</strong> area substandard<br />

and capable <strong>of</strong> putting the health <strong>of</strong> pregnant women at unacceptable risk. We made the<br />

following recommendations:<br />

1. A periodic exchange <strong>of</strong> staff between primary, secondary and tertiary health<br />

institutions should be encouraged as a way <strong>of</strong> improving the knowledge base and<br />

skills <strong>of</strong> healthcare providers in these facilities.<br />

2. Healthcare workers in PHCs should be encouraged to attend periodic update courses.<br />

3. Regular internal and periodic external audit <strong>of</strong> the clinical activities at PHCs should<br />

be considered.<br />

11


4. Posters <strong>of</strong> high-risk obstetric factors requiring referral should be placed in strategic<br />

areas in the consulting rooms at PHCs to serve as reminders for the healthcare<br />

workers.<br />

5. Basic infrastructure in PHCs should be provided and maintained.<br />

6. Each local government area should consider appointing a supervising consultant<br />

obstetrician to maintain the standard <strong>of</strong> services in its PHCs.<br />

PHCs in <strong>Jos</strong> are better staffed in comparison to PHCs in more rural communities in the State<br />

(see Table 1). The poor antenatal services observed in PHCs around <strong>Jos</strong> are therefore likely to<br />

be a more generalized problem. Sub-standard care in this situation does not only put pregnant<br />

women‘s lives at risk but it represents a missed opportunity to impact positively on the poor<br />

maternal and perinatal health statistics in the area.<br />

4. Are there any concerns about survival <strong>of</strong> the newborn?<br />

The global burden <strong>of</strong> newborn illness shows that a disparity <strong>of</strong> up to 30-folds exists between<br />

countries with highest and lowest newborn death statistics. Four million babies die in<br />

developing countries annually and about 42% <strong>of</strong> these deaths are due to infections. Other<br />

major causes include perinatal asphyxia (21%), birth injuries (11%), prematurity and low<br />

birth weight (10%) and congenital abnormalities (11%). It was also observed that two-thirds<br />

<strong>of</strong> the deaths in the neonatal period occur in the first week; among these deaths, two-thirds<br />

occurred within the first 24 hours.<br />

skilled care at facility levels such as emergency obstetric care services are<br />

recommended for saving maternal and newborn lives (Bhutta et al 2008).<br />

scale-up <strong>of</strong> community and household care are necessary for improving<br />

newborn and child survival<br />

Programmes that are necessary for the reduction in neonatal morbidity and mortality rates are<br />

for countries to employ rational mix <strong>of</strong> quality clinical services, effective public health<br />

measures and inexpensive community-based interventions in public and private sectors and to<br />

scale-up known cost-effective interventions such as the mother-baby packages. (Sule and<br />

Onayade 2006). Strengthening Maternal Newborn and Child Health services at the primary<br />

health-care level should be a priority for countries to reach their Millennium Development<br />

Goal targets for reducing maternal and child mortality.<br />

5. Are there emerging challenges to motherhood in the HIV era?<br />

Trend <strong>of</strong> HIV prevalence in women in Plateau State<br />

Our study <strong>of</strong> the HIV epidemic in pregnant women in Nigeria started in 1999 when we<br />

reported the yearly trend <strong>of</strong> HIV sero-prevalence among pregnant women in <strong>Jos</strong> over a 10year<br />

period (1989 – 1998). A total <strong>of</strong> 11,059 pregnant women were screened and 134 (1.24%)<br />

were HIV positive. The yearly trend showed a rise in HIV sero-prevalence from 0.25% (1 in<br />

394) in 1989 to 3.69% (1 in 27) in 1997(<strong>Sagay</strong> et al 1999). The trend <strong>of</strong> yearly HIV<br />

prevalence among pregnant women from 1989 to 2001 is shown in Figure 1.<br />

12


Figure 1: Diagram shows rising trend <strong>of</strong> HIV infection in pregnant women in <strong>Jos</strong>, Nigeria<br />

% HIV Positive<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

0.25<br />

Yearly HIV Seroprevalence Among Pregnant<br />

Women in <strong>Jos</strong>, Nigeria 1989-2001<br />

0.38 0.4<br />

0.71<br />

1.71<br />

2.21<br />

Year<br />

We believed that the 16-fold rise in prevalence <strong>of</strong> HIV infection among pregnant women in<br />

<strong>Jos</strong> over a 10-year period was a reflection <strong>of</strong> the trend in the general population. In the<br />

absence <strong>of</strong> interventions, 30% to 40% <strong>of</strong> HIV- exposed infants will become HIV infected<br />

through mother-to-child transmission. The implications <strong>of</strong> this rising prevalence <strong>of</strong> HIV in<br />

pregnant women and what it portends for child survival in the absence <strong>of</strong> interventions to<br />

prevent mother-to-child transmission (PMTCT) provided the impetus for our further studies<br />

to identify local risk factors and possible intervention strategies.<br />

Documentation <strong>of</strong> higher prevalence <strong>of</strong> cervical abnormalities in <strong>Jos</strong><br />

Another challenge that we documented was the higher prevalence <strong>of</strong> cervical abnormalities<br />

which could not be directly attributed to the increasing HIV epidemic. Cancer <strong>of</strong> the cervix is<br />

essentially a sexually transmitted disease and it occurs more commonly among women who<br />

have delivered many children. Cervical pre-cancer lesions are more common among HIV<br />

infected women when compared with HIV negative controls (40% versus 17%) (Massad et al<br />

1999) and it correlates with lower CD4+ cell counts (Schafer et al 1991). We reported the<br />

doubling (7.7% in 1990 vs 14.6% in 2002) in prevalence <strong>of</strong> CIN in <strong>Jos</strong> over a decade <strong>of</strong><br />

expanding HIV epidemic (<strong>Sagay</strong> et al 2008.) Recently, we also reported a much higher rate<br />

<strong>of</strong> CIN (24.6%) among female sex workers in <strong>Jos</strong> (<strong>Sagay</strong> et al 2009). These findings<br />

highlight anticipated challenges with cervical cancer in the near future if prevention,<br />

screening and treatment interventions are not implemented. With the advent <strong>of</strong> human<br />

papilloma virus vaccine, the prospect <strong>of</strong> achieving wide spread primary prevention cannot be<br />

brighter. The quadrivalent human papillomavirus (HPV) vaccine, marketed under the name<br />

Gardasil®, is a recombinant vaccine that is effective against HPV types 6, 11, 16, and 18.<br />

The vaccine received approval for the prevention <strong>of</strong> cervical, vulvar, and vaginal<br />

intraepithelial lesions and genital warts associated with the vaccine HPV types. The vaccine<br />

is administered to girls aged 9-26 years in 3 doses over a 6-month period. The complete cost<br />

per client is about 400USD or N60, 000.<br />

13<br />

3.21<br />

3.28<br />

3.69<br />

3.92<br />

4.13<br />

4.56<br />

4.82


Risk factors for HIV infection in pregnant women in <strong>Jos</strong><br />

As part the national program for prevention <strong>of</strong> mother-to-child transmission (PMTCT) <strong>of</strong><br />

HIV, the AIDS Prevention Initiative in Nigeria (APIN) developed HIV voluntary counselling<br />

and testing services at JUTH antenatal clinic in October 2001. Between April 2002 and<br />

November 2003, we conducted a study to determine the risk factors for HIV and other<br />

sexually transmitted infections (STIs) among pregnant women participating in the PMTCT<br />

programme at JUTH. During this period, antiretroviral (ARV) intervention for PMTCT using<br />

single-dose Nevirapine was introduced. This study documented risk factors <strong>of</strong> HIV infection<br />

in pregnant women which are outlined below in tables 2a, 2b, 2c and 2d.<br />

HIV Risk Factors in Pregnant Women in Nigeria:<br />

a. Age, religion and alcohol<br />

Among pregnant women in <strong>Jos</strong>, Nigeria, HIV prevalence was lowest in teenagers and the<br />

over 40s. Women aged 20 to 29 years had a 4-fold higher prevalence <strong>of</strong> HIV infection.<br />

Compared to women who reported to be Moslems, women <strong>of</strong> all Christian denominations had<br />

significantly increased risk <strong>of</strong> HIV. This was more so among Pentecostals and Catholics.<br />

Women who admitted to taking alcohol had significantly increased risk <strong>of</strong> HIV.<br />

Table 2a: The associations between age, religion and alcohol use and HIV-1 infection<br />

among pregnant women in <strong>Jos</strong>, Nigeria (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />

Predictor<br />

Age (years completed)<br />

40<br />

Don’t know<br />

Religion<br />

Moslem<br />

Catholic<br />

Pentecostal<br />

Protestant<br />

Traditional/other<br />

Missing<br />

Do you drink alcohol?<br />

No<br />

Yes<br />

Missing<br />

N (%) % HIV<br />

positive<br />

182 (6.8)<br />

618 (23.3)<br />

887 (33.4)<br />

607 (22.8)<br />

276 (10.4)<br />

54 (2.0)<br />

33 (1.2)<br />

802 (30.2)<br />

477 (18.0)<br />

383 (14.4)<br />

953 (35.9)<br />

15 (0.6)<br />

27 (1.0)<br />

24 (93.8)<br />

125 (4.7)<br />

41 (1.5)<br />

b. Marital Status and Husband’s Occupation<br />

14<br />

2.2<br />

8.3<br />

10.9<br />

7.7<br />

5.4<br />

1.9<br />

6.1<br />

5.1<br />

9.6<br />

10.2<br />

9.3<br />

0.0<br />

0.9<br />

7.9<br />

13.6<br />

4.9<br />

Crude OR (95% CI) a Adjusted OR (95%<br />

CI) b<br />

1.00<br />

4.00 (1.43-11.22)<br />

5.46 (1.98-15.03)<br />

3.73 (1.33-10.50)<br />

2.56 (0.83-7.82)<br />

0.84 (0.09-7.67)<br />

2.87 (0.50-16.34)<br />

1.00<br />

1.98 (1.28-3.07)<br />

2.10 (1.33-3.32)<br />

1.91 (1.30-2.80)<br />

-<br />

1.48 (0.34-6.48)<br />

1.00<br />

1.83 (1.07-3.10)<br />

0.59 (0.14-2.48)<br />

1.00<br />

4.57 (1.3-15.46)<br />

4.44 (1.32-14.88)<br />

3.00 (0.86-10.40)<br />

1.69 (0.44-6.43)<br />

0.47 (0.04-5.38)<br />

1.05 (0.01-11.39)<br />

1.00<br />

1.72 (1.01-2.95)<br />

2.57 (1.46-4.52)<br />

1.50 (0.93-2.44)<br />

-<br />

-<br />

Women who were married only once had a low risk <strong>of</strong> HIV. In comparison, the risk <strong>of</strong><br />

HIV was increased among women who reported multiple marriages and in unmarried<br />

women. The risk <strong>of</strong> HIV was also increased among women whose husbands were


ankers or accountants.<br />

Table 2b. The associations between marital status and husband’s occupation, and HIV-1<br />

infection among pregnant women in <strong>Jos</strong>, Nigeria (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />

Predictor<br />

Marital status<br />

Married only once<br />

Married more than once<br />

Not married (single/div/sep)<br />

Missing<br />

Occupation <strong>of</strong> husband/partner<br />

Civil servant<br />

Banker/accountant<br />

Business<br />

Drivers (truck, taxi, motorcycle)<br />

Other<br />

Missing<br />

Not married<br />

N (%) % HIV<br />

positive<br />

2429 (91.4)<br />

161 (6.1)<br />

39 (1.5)<br />

28 (1.1)<br />

830 (31.2)<br />

72 (2.7)<br />

858 (32.3)<br />

181 (6.8)<br />

557 (21.0)<br />

120 (4.5)<br />

39 (1.5)<br />

15<br />

7.4<br />

16.1<br />

23.1<br />

7.1<br />

8.6<br />

20.8<br />

6.9<br />

5.5<br />

7.4<br />

10.0<br />

23.1<br />

Crude OR (95%<br />

CI) a<br />

1.00<br />

2.41 (1.54-3.76)<br />

3.75 (1.75-8.02)<br />

0.96 (0.23-4.08)<br />

1.00<br />

2.81 (1.51-5.22)<br />

0.79 (0.55-1.13)<br />

0.63 (0.32-1.24)<br />

0.85 (0.57-1.27)<br />

1.19 (0.62-2.26)<br />

3.21 (1.46-7.02)<br />

c. Circumcision, No. Of Sex Partners, Sex Network and Perceived Risk <strong>of</strong> HIV<br />

Adjusted OR (95%<br />

CI) b<br />

1.00<br />

3.06 (1.74-5.39)<br />

2.08 (0.67-6.47)<br />

_<br />

1.00<br />

2.88 (1.28-6.45)<br />

1.10 (0.71-1.70)<br />

0.87 (0.40-191)<br />

0.97 (0.60-1.57)<br />

_<br />

_<br />

Women who reported to be circumcised (13.3%) had relatively reduced risk <strong>of</strong> HIV<br />

(OR=0.59, 95% CI=0.36-0.96). Women’s level <strong>of</strong> education and occupation were not<br />

associated with HIV. The risk <strong>of</strong> HIV increased with increasing number <strong>of</strong> sex partners<br />

in the past 5 years. Women who were aware that their last male partner had other sex<br />

partners were at increased risk <strong>of</strong> HIV. About 51% <strong>of</strong> women knew someone who was<br />

living with HIV or died from AIDS, while 17.6% had a close relative who was living with<br />

HIV or died from AIDS. These women had increased risk <strong>of</strong> HIV. Compared to women<br />

who perceived themselves to be at no risk <strong>of</strong> HIV, the risk <strong>of</strong> HIV was significantly<br />

increased in all other women. Women who had abnormal vaginal discharge in the last<br />

12 months were also at increased risk <strong>of</strong> HIV infection.


Table 2c. The associations between selected potential risk factors and HIV-1 infection<br />

among pregnant women in <strong>Jos</strong>, Plateau State, Nigeria. (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />

Predictor<br />

Number <strong>of</strong> sex partners in the last 5 years<br />

1<br />

2<br />

>3<br />

Missing<br />

p-value, test for linear trend<br />

Last male partner has other partners?<br />

No<br />

Yes<br />

Don’t know<br />

What are your chances <strong>of</strong> contracting<br />

HIV/AIDS?<br />

No risk at all<br />

Minimal/small risk<br />

Moderate risk<br />

Great risk<br />

Don’t know<br />

p-value, test for linear trend<br />

Had abnormal genital discharge during the<br />

last 12 months<br />

No<br />

Yes<br />

Don’t know<br />

N (%) % HIV<br />

positive<br />

2003 (75.4)<br />

349 (13.1)<br />

128 (4.8)<br />

177 (6.7)<br />

1680 (63.2)<br />

162 (6.1)<br />

815 (30.7)<br />

1607 (61.7)<br />

388 (14.9)<br />

68 (2.6)<br />

25 (0.9)<br />

518 (19.9)<br />

8866 (70.2)<br />

661 (24.9)<br />

130 (4.9)<br />

16<br />

5.7<br />

13.2<br />

19.5<br />

17.5<br />

5.8<br />

22.8<br />

10.2<br />

4.1<br />

7.2<br />

17.6<br />

20.0<br />

11.0<br />

6.3<br />

14.1<br />

5.4<br />

d. Sexually Transmitted Infections (STIs) and HIV Risk<br />

Crude OR (95% CI) a Adjusted OR<br />

(95% CI) b<br />

1.00<br />

2.49 (1.73-3.85)<br />

3.98 (2.48-6.41)<br />

3.49 (2.27-5.36)<br />

0.001<br />

1.00<br />

4.83 (3.17-7.35)<br />

1.85 (1.36-2.51)<br />

1.00<br />

1.82 (1.15-2.87)<br />

5.00(2.56-9.78)<br />

5.84 (2.12-16.03)<br />

2.89 (1.99-4.18)<br />


Table 2d. The associations between selected potential risk factors and HIV-1 infection<br />

among pregnant women in <strong>Jos</strong>, Plateau State, Nigeria. (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />

Predictor<br />

Had genital ulcer during the last 12<br />

months or at the time <strong>of</strong> exam.<br />

No<br />

Yes<br />

Don’t know or not examined<br />

Candida albicans<br />

Negative<br />

Positive<br />

Samples not provided<br />

Trichomonas vaginalis<br />

Negative<br />

Positive<br />

Samples not provided<br />

Active (recent) syphilis<br />

Negative<br />

Positive<br />

Samples not provided<br />

Disturbance <strong>of</strong> vaginal flora<br />

Normal flora<br />

Mild disturbances<br />

Moderate disturbances<br />

Severe disturbances (Bacterial Vaginosis)<br />

Samples not provided<br />

N (%) % HIV<br />

positive<br />

2422 (91.2)<br />

132 (5.0)<br />

103 (3.9)<br />

2226 (83.8)<br />

391 (14.7)<br />

40 (1.5)<br />

575 (96.9)<br />

41 (1.5)<br />

41 (1.5)<br />

627 (98.8)<br />

7 (0.3)<br />

23 (0.9)<br />

185 (7.0)<br />

1677 (63.2)<br />

288 (10.8)<br />

466 (17.5)<br />

41 (1.5)<br />

17<br />

7.0<br />

28.8<br />

9.7<br />

7.3<br />

13.0<br />

10.0<br />

8.0<br />

14.6<br />

12.2<br />

8.0<br />

42.9<br />

17.4<br />

7.6<br />

6.5<br />

10.4<br />

12.7<br />

12.2<br />

Prevention <strong>of</strong> Mother-to-Child Transmission <strong>of</strong> HIV<br />

Crude OR (95%<br />

CI) a<br />

1.00<br />

5.39 (3.58-8.10)<br />

1.43 (0.73-2.80)<br />

1.00<br />

1.91 (1.37-2.67)<br />

1.41(0.5-4.03)<br />

1.00<br />

1.97 (0.82-4.74)<br />

1.60 (0.62-4.11)<br />

1.00<br />

8.63 (1.92-38.82)<br />

2.42 (0.82-7.19<br />

1.00<br />

0.85 (0.48-1.51)<br />

1.42 (0.73-2.76)<br />

1.77 (0.96-3.26)<br />

1.70 (0.57-5.01)<br />

Adjusted OR (95%<br />

CI) b<br />

1.00<br />

3.35 (2.00-5.61)<br />

-<br />

1.00<br />

2.23 (1.49-3.36)<br />

-<br />

1.00<br />

16.88 (2.88-98.76)<br />

-<br />

1.00<br />

1.68 (0.78-3.62)<br />

2.40 (1.03-5.60)<br />

2.77 (1.25-6.13)<br />

-<br />

Mother-to-child transmission (MTCT) <strong>of</strong> HIV is the most significant source <strong>of</strong> HIV infection in<br />

children below the age <strong>of</strong> 10 years. To prevent mother to child transmission <strong>of</strong> HIV, World<br />

Health Organization recommends a four-pronged strategy. This includes: (i) the primary<br />

prevention <strong>of</strong> HIV infection among parents to be; (ii) the prevention <strong>of</strong> unwanted pregnancies<br />

(including safe abortion where permitted by law) in HIV-infected women; and (iii) the<br />

prevention <strong>of</strong> HIV transmission from infected women to their infants and (iv) the treatment,<br />

care and support <strong>of</strong> infected and affected women, their infants and young children, partners and<br />

families.<br />

Nigeria national response<br />

The expanding HIV epidemic nationally prompted the establishment <strong>of</strong> a national prevention <strong>of</strong><br />

mother-to-child transmission (PMTCT) <strong>of</strong> HIV program in 2001. The program started with a<br />

formative research in 2001 while counselling, testing and the administration <strong>of</strong> single-dose<br />

Nevirapine intervention regimen commenced in 8 tertiary health facilities in July 2002. With<br />

funding support from Center for Disease Control (CDC), Atlanta, USA in2003, interventions<br />

started in 3 additional tertiary facilities, bring the total to 11 sites. Evaluation <strong>of</strong> the program in<br />

2004 showed a national coverage <strong>of</strong> about 1% <strong>of</strong> eligible pregnant women and this poor


coverage was the impetus for scaling up efforts. The national PMTCT Program expansion efforts<br />

enjoyed substantial donor support, and services have currently reached about 650 sites.<br />

Expansion <strong>of</strong> PMTCT services in Plateau State<br />

With support from APIN, we embarked on the expansion <strong>of</strong> PMTCT services in Plateau State in<br />

2004. This project was my sabbatical leave assignment with APIN. We adopted a stepwise<br />

approach as outlined below:<br />

Mapping <strong>of</strong> maternity care services in Plateau State.<br />

Selection <strong>of</strong> phase 1 implementation sites based on; HIV prevalence in facility, volume <strong>of</strong><br />

ANC clientele and geography.<br />

Engagement <strong>of</strong> institutional leadership through advocacy to promote buy-in., Facility<br />

assessment, Renovation, Personnel capacity building (trainings), provision <strong>of</strong> necessary<br />

equipment and commencement <strong>of</strong> PMTCT services using national guidelines and<br />

registers.<br />

Figure 2: New Antenatal Care Bookings by LGAs in 2004<br />

18


Figure 3: Health Facility Deliveries by LGAs in 2004<br />

Figure 4: Health Facility HIV prevalence rates in Plateau State by LGAs in 2004<br />

19


Figure 5: Level <strong>of</strong> PMTCT Services by LGAs in Plateau State 2004<br />

In 2006, this drive snowballed to HIV/AIDS comprehensive treatment and care program<br />

through additional funding from Harvard PEPFAR. Services were decentralization to all the 17<br />

local government areas <strong>of</strong> Plateau State. Service provision in the following areas were<br />

supported: Adult antiretroviral therapy, PMTCT, Paediatric antiretroviral therapy, Infant<br />

feeding and nutrition counseling, Family planning, Cervical cancer screening, Malaria<br />

prophylaxis interventions, Tuberculosis screening and Orphans and vulnerable children (OVC)<br />

support. The diagram below shows the activity pyramid <strong>of</strong> the program.<br />

47<br />

Activity Pyramid<br />

14<br />

1<br />

20<br />

APIN<br />

JUTH<br />

SATELLITES<br />

SITES<br />

PRIMARY HEALTH<br />

CARE FACILITIES<br />

COMMUNITY<br />

Figure 6: Activity Pyramid <strong>of</strong> PMTCT Decentralization in Plateau State, Nigeria


Figure 7: Hub and Spoke Illustration <strong>of</strong> PMTCT Sites in Plateau State, Nigeria<br />

The mapping exercise reported that in 2004, 71,655 pregnant women booked for antenatal care<br />

and 22,640 women delivered in the 193 health facilities providing maternity services in the 17<br />

LGAs <strong>of</strong> Plateau State. In 2004, only 5,500 pregnant women in 2 LGAs accessed PMTCT services,<br />

giving PMTCT coverage <strong>of</strong> 6.5%. Subsequent PMTCT expansion efforts supported principally by<br />

APIN and also by other partners, led to the availability <strong>of</strong> PMTCT services in all 17 LGAs by<br />

2007. In 2008, 42,120 pregnant women accessed PMTCT interventions across Plateau State<br />

giving coverage <strong>of</strong> 47.5% according to 2006 population census. From conservative estimates<br />

based on these figures, about 300 infant HIV infections were averted in Plateau State in 2008<br />

alone.<br />

About 300 infant HIV infections are averted each year in Plateau State<br />

through PMTCT interventions<br />

HIV testing and counseling in labour as entry point for PMTCT<br />

The highest risk <strong>of</strong> mother-to-child transmission (MTCT) <strong>of</strong> HIV-1 infection occurs during<br />

labour and delivery. Findings from clinical trials show that antiretroviral (ARV) prophylaxis,<br />

given to the mother during labour and delivery and to the neonate immediately after birth, can<br />

reduce MTCT <strong>of</strong> HIV by as much as 50% (Moodley D et al 2003).<br />

Thus, provision <strong>of</strong> routine HIV testing to women with unknown HIV status during labour and<br />

delivery can contribute in reducing MTCT. We demonstrated the feasibility <strong>of</strong> providing rapid<br />

HIV testing and counselling, using the “opt out” approach, in the labour ward <strong>of</strong> JUTH (<strong>Sagay</strong> et<br />

al 2006). Among 164 women with unknown HIV status before labour, 14 (8.6%) were detected<br />

to be HIV positive in labour. In all, a total <strong>of</strong> 340 (99.8%) <strong>of</strong> the 431 pregnant women who were<br />

<strong>of</strong>fered HIV testing in labour accepted testing. Of the 235 women who previously tested HIV<br />

negative during pregnancy, 5 (2.1%) were found to be HIV positive in labour (see Table 3). The<br />

practice <strong>of</strong> rapid HIV testing and counselling in labour provides a final opportunity to detect<br />

21


pregnant women with HIV infection, who may require interventions to prevent MTCT. This was<br />

the first study to demonstrate the feasibility <strong>of</strong> this practice in labour ward settings in Nigeria.<br />

Table 3: HIV status prior to labour and HIV status after testing in labour (<strong>Sagay</strong> et al 2006).<br />

HIV Status prior to Labour Tested HIV Neg in<br />

Labour<br />

22<br />

Tested HIV Pos in<br />

Labour<br />

Negative 230 5 (2.1%) 235<br />

Positive 1 27 28<br />

Unknown 150 16 (9.6%) 166<br />

Indeterminate 0 1 1<br />

Total<br />

381 (88.6%) 49 (11.4%) 430<br />

HIV Sero-discordance among couples in PMTCT settings in Nigeria<br />

In 2005, we conducted this study to determine the pattern <strong>of</strong> HIV sero-status <strong>of</strong> Partners <strong>of</strong><br />

HIV Positive Pregnant Women in three different regions <strong>of</strong> Nigeria and to explore the<br />

implications for HIV prevention interventions. The study was conducted in Benin City, <strong>Jos</strong><br />

and Kano after consideration <strong>of</strong> their ethnic, religious and cultural representation <strong>of</strong> Nigeria.<br />

The city-by-city results showed that in Benin City (Southern Nigeria), 78.8% (104/132) <strong>of</strong><br />

the partners were HIV negative (sero-discordant), <strong>Jos</strong> (Middle-Belt) had 48.4% (103/213)<br />

sero-discordance while Kano (Northern Nigeria) recorded a sero-discordance rate <strong>of</strong> only<br />

7.7% (12/155) (see Figure 8).<br />

Figure 8: Prevalence <strong>of</strong> HIV Sero-discordant Couples with<br />

Positive Female Partners in Nigeria<br />

Oyo<br />

Ogun<br />

Lagos<br />

Kebbi<br />

Osun<br />

Kwara<br />

<strong>Sagay</strong> AS, et al AJMMS 2006<br />

Sokoto<br />

Ekiti<br />

Ondo<br />

Niger<br />

Edo<br />

Delta<br />

Zamfara<br />

Kogi<br />

78.8%<br />

FCT<br />

Anam<br />

bra<br />

Imo<br />

Bayelsa Rivers<br />

Katsina<br />

Kaduna<br />

Abia<br />

Akwa<br />

Ibom<br />

Kano<br />

Nasarawa<br />

Ebonyi<br />

7.7%<br />

Benue<br />

Cross<br />

River<br />

Jigawa<br />

Bauchi<br />

Plateau<br />

48.8%<br />

Taraba<br />

Gombe<br />

Yobe<br />

Adamawa<br />

Borno


The study documented a high prevalence <strong>of</strong> prevalence <strong>of</strong> HIV sero-discordance in marital<br />

settings in Benin and <strong>Jos</strong> and substantiated the observation that unlike most sexually<br />

transmitted diseases (STDs), HIV is not very infectious in heterosexual relationships, unless<br />

the transmission is assisted in some way. The chance in one sexual act <strong>of</strong> transmission<br />

between partners who are disease-free except that one is HIV-positive may be as low as one<br />

in 1000 from woman to man and one in 300 from man to woman (Caldwell et al. 1995).<br />

These are not levels <strong>of</strong> infection which give rise to epidemics, and this is the reason why most<br />

societies with STD control programs are not at risk <strong>of</strong> a heterosexual epidemic. In the United<br />

States only 7% <strong>of</strong> transmission is heterosexual, as is 10% in Europe (Way et al. 1994).<br />

These results also indicate that the dynamics <strong>of</strong> HIV transmission in marital settings in<br />

Nigeria are different in the various regions <strong>of</strong> the country. We concluded as follows, that:<br />

HIV sero-discordance rates in marital settings in Southern Nigeria are among the<br />

highest globally<br />

Studies to unravel the high rate <strong>of</strong> HIV sero-discordance in Benin-City may yield<br />

dividends in the prevention <strong>of</strong> heterosexual transmission in Nigeria. This may not be<br />

unconnected to the almost 100% male circumcision in childhood and easy access to<br />

medical treatment <strong>of</strong> sexually transmitted infections.<br />

In cultures where women are emancipated (Benin), the general direction <strong>of</strong><br />

heterosexual transmission <strong>of</strong> HIV in marital settings is from women to men while the<br />

reverse situation occurs in cultures that are restrictive on women (Kano).<br />

Primary HIV prevention strategies in predominantly Christian communities where<br />

women are emancipated should target young women while Moslem communities<br />

must target the males<br />

Disclosure <strong>of</strong> HIV sero-status in PMTCT settings in Nigeria<br />

Partner consent and support can substantially enhance adherence to PMTCT interventions. This<br />

is particularly true <strong>of</strong> the Nigerian setting where significant others such as mother-in-laws have<br />

a big role in determining postnatal interventions. In this study, we explored the issues<br />

concerning disclosure <strong>of</strong> HIV status to partners <strong>of</strong> HIV sero-positive mothers in our PMTCT<br />

programme in <strong>Jos</strong>, Nigeria.<br />

A total <strong>of</strong> 570 HIV positive mothers in the PMTCT clinic were studied. Eighty nine percent<br />

(500/560) <strong>of</strong> the women have disclosed their HIV status to their partners. Of these, about<br />

40% (199/502) required the assistance <strong>of</strong> health workers while 60% (298/502) did it by<br />

themselves. Following disclosure <strong>of</strong> HIV status, 86.9% (430/495) <strong>of</strong> the partners were<br />

supportive, 5.7% were indifferent, 6.7% were quarrelsome and abusive while 1.0% were<br />

violent. Seventy four percent (419/563) <strong>of</strong> the mothers were aware <strong>of</strong> their husband‘s HIV<br />

sero-status. Of these, 65.4 %( 274/419) <strong>of</strong> the partners were HIV positive while 34.6% were<br />

sero-negative.<br />

Based on these findings, we concluded that the reactions <strong>of</strong> partners <strong>of</strong> HIV positive mothers<br />

to disclosure <strong>of</strong> their wives‘ HIV status are predominantly supportive and felt that this should<br />

strengthen strategies to promote partner disclosure (<strong>Sagay</strong> et al. 2006).<br />

23


Outcome <strong>of</strong> PMTCT interventions in Nigeria<br />

We have analysed the mother-to-child transmission (MTCT) rates following various<br />

interventions at JUTH and these are shown in green bars in figure 9 above. The transmission<br />

rates at 6 weeks <strong>of</strong> age are compared with MTCT rates in Botswana, a country that can boast <strong>of</strong><br />

some <strong>of</strong> the best PMTCT programs in Africa.<br />

15%<br />

10%<br />

5%<br />

0%<br />

Figure 9: ARV Interventions and<br />

MTCT [Nigeria vs. Botswana]<br />

BOTSWANA<br />

JOS, NIGERIA<br />

0.7%<br />

0.9%<br />

2.3%<br />

3.3%<br />

2.9%<br />

Pre-preg During 4wks<br />

HAART AZT+sdNVP<br />

4.7%<br />

24<br />

7.0%<br />

5.2%<br />

sdNVP<br />

alone<br />

12.3%<br />

12.6%<br />

No ART<br />

Clearly, outcomes in our programme are comparable indicating that our interventions are<br />

working like elsewhere in the world.<br />

Infant feeding and MTCT between 6wks and 6months<br />

One <strong>of</strong> the strategies to reduce postnatal mother to child transmission (MTCT) <strong>of</strong> HIV is the use<br />

<strong>of</strong> replacement feeding (BMS) which is expected to eliminate transmission through breast milk.<br />

To achieve this goal, BMS must be practiced in a setting where it is culturally acceptable,<br />

feasible, affordable, sustainable and safe (AFASS), otherwise, there is increased risk <strong>of</strong> infant<br />

morbidity and mortality.<br />

The vast majority <strong>of</strong> our HIV infected mothers are provided with infant formula (BMS) to<br />

prevent HIV transmission to their babies. Our recent unpublished study compared the risk <strong>of</strong><br />

postnatal transmission <strong>of</strong> HIV at 6 months among infants who are HIV negative at 6 weeks <strong>of</strong><br />

age and were exclusively breast fed or given exclusive replacement feeding in the PMTCT<br />

program at JUTH, <strong>Jos</strong>, Nigeria. The difference in transmission risk between the two feeding<br />

methods was not statistically significant (1.8% vs 2.2%; P value =0.785). This finding showed<br />

that many mothers in the BMS group were practicing mixed feeding. New guidelines endorse<br />

administration <strong>of</strong> antiretroviral drugs to make breast feeding safer. It is hoped that this strategy<br />

will improve child survival without increasing HIV transmission to the infant.


Evidence <strong>of</strong> declining prevalence<br />

The last three HIV sero-sentinel surveys have consistently showed a declining trend in HIV<br />

prevalence among pregnant women. HIV prevalence in Plateau State has declined from 8.5%<br />

in 2001 to 2.6% in 2008 (see Figure 10). The reasons are not unconnected with the State-wide<br />

interventions by all stakeholders. I am proud to continue to be part <strong>of</strong> these efforts.<br />

Prevalence (%)<br />

Figure 10: HIV Prevalence trend in States that showed a<br />

defined consistent pattern 2001 - 2008<br />

8.5<br />

8.2<br />

6.8<br />

3.5<br />

3.2<br />

3.3<br />

Key points and Conclusions<br />

9.0<br />

8.0<br />

7.0<br />

6.0<br />

5.0<br />

4.0<br />

3.0<br />

2.0<br />

1.0<br />

0.0<br />

6.8<br />

6.3<br />

4.8<br />

3.7<br />

3.3<br />

2.0<br />

2001 2003 2005 2008<br />

Year<br />

25<br />

4.9<br />

Plateau Bauchi Ekiti Gombe Zamfara Abia<br />

Infertile women in Nigerian face tremendous socio-cultural challenges and perhaps as<br />

a consequence, have a high prevalence <strong>of</strong> psychological problems. Government<br />

support for assisted reproductive technologies, as obtainable in developed countries<br />

like the United Kingdom, may mitigate the impact <strong>of</strong> this widely prevalent malady.<br />

There is no experience more difficult than having to go through a miscarriage time<br />

and time again. Miscarriage is not only physically taxing, but very emotionally<br />

challenging, as well. A small proportion <strong>of</strong> couples in Nigeria experience recurrent<br />

pregnancy losses (when a woman loses three or more consecutive pregnancies). The<br />

management <strong>of</strong> this condition remains a challenge for gynaecologists.<br />

Each year, thousands <strong>of</strong> Nigerian women have unintended pregnancies that end in<br />

illegal abortion. Many <strong>of</strong> such procedures occur under unsafe conditions, contributing<br />

to maternal morbidity and mortality. Substantial investment in culturally appropriate<br />

family planning messaging and making contraception services available, affordable<br />

and accessible to all women (including youths) as a component <strong>of</strong> safe motherhood<br />

programs is required.<br />

4.0<br />

3.4<br />

3.0<br />

1.6<br />

5.0<br />

4.0<br />

3.1<br />

2.6<br />

2.1<br />

1.0


References<br />

Too many mothers and newborns are dying in Nigeria. We know what needs to be done<br />

to save these lives. The real challenges are how to deliver services and scale up interventions,<br />

particularly to those who are vulnerable, hard to reach, marginalized and<br />

excluded. Innovative, non-governmental ways <strong>of</strong> reactivating, supervising and<br />

monitoring services in primary healthcare centres across Nigeria should be a top<br />

priority.<br />

The HIV epidemic is an emerging threat to maternal and newborn lives. Existing<br />

prevention and treatment interventions are efficacious but must be scaled up to<br />

achieve the desired impact.<br />

In Nigeria, the HIV epidemic is driven by heterosexual transmission. In heterosexual<br />

settings, HIV does not stand alone. It requires the support <strong>of</strong> other STDs to stand. This<br />

is why most societies with STD control programs are not at risk <strong>of</strong> a heterosexual<br />

HIV epidemic. In addition to existing HIV interventions, resuscitation <strong>of</strong> STD control<br />

programs nationally is required to control the present HIV scourge.<br />

1. <strong>Sagay</strong> AS, Udoeyop EU, Pam IC, Karshima JA, Daru PH, Otubu J.A.M.<br />

Laparoscopic Evaluation <strong>of</strong> 1000 Consecutive Infertile Women in <strong>Jos</strong>, Nigeria.<br />

Tropical Journal <strong>of</strong> Obstetrics and Gynaecology. 1998, 15(1):30-35.<br />

2. Imade G.E. <strong>Sagay</strong> A.S., Pam I.C., Daru P.H. Semen Quality <strong>of</strong> Male Partners <strong>of</strong><br />

Infertile Couples in <strong>Jos</strong>, Nigeria. Tropical Journal <strong>of</strong> Obstetrics and Gynaecology.<br />

2000, 17(1):24-26.<br />

3. Hollos M, Larsen U, Obono O, Whitehouse B. The problem <strong>of</strong> infertility in high<br />

fertility populations: meanings, consequences and coping mechanisms in two<br />

Nigerian communities. Soc Sci Med. 2009 Jun; 68(11):2061-8.<br />

4. Friday E. Okon<strong>of</strong>ua, Diana Harris, Adetanwa Odebiyi, Thomas Kane and Rachel<br />

C. Snow The social meaning <strong>of</strong> infertility in Southwest Nigeria Health Transition<br />

Review 7, 1997, 205-220.<br />

5. Aghanwa HS, Dare FO, Ogunniyi SO. Sociodemographic factors in mental disorders<br />

associated with infertility in Nigeria. Psychosom Res. 1999 Feb; 46(2):117-23.<br />

6. Guttmacher Institute. In Brief; Reducing unsafe abortion in Nigeria, 2008 Series,<br />

No.3 Pp: 1-4.<br />

7. Bankole A, Oye-Adeniran BA, Singh S, Adewole I, Wulf D, Sedgh G,Hussain R.<br />

Unwanted Pregnancy and Induced Abortion in Nigeria: Causes and Consequences,<br />

New York: Guttmacher Institute, 2006<br />

8. World Health Organization (WHO), Maternal Mortality in 2005: Estimates<br />

Developed by WHO, UNICEF, UNFPA and the World Bank, Geneva: WHO, 2007.<br />

26


9. Henshaw SK, Adewole I, Singh S, Bankole A, Oye-Adeniran B, Hussain R., Severity<br />

and cost <strong>of</strong> unsafe abortion complications treated in Nigerian hospitals, International<br />

Family Planning Perspectives, 2008, 34(1):40–50.<br />

10. World Health Organization (WHO), Maternal Mortality in 2005: Estimates<br />

Developed by WHO, UNICEF, UNFPA, and the World Bank, Geneva: WHO, 2007.<br />

11. Otubu JAM, Towobola AO, Aisien AO, Da’or R, Uguru VE. Female sterilization by<br />

minilaparotomy: The JUTH experience. Trop J Obstet Gynaecol. 1990; 21: 26-28.<br />

12. Aisien AO, Olarewaju RS, Ujah IAO, Mutihir JT, <strong>Sagay</strong> AS. Anaesthesia for<br />

Minilaparotomy Female Sterilization in JUTH, Nigeria: A fourteen-year review.<br />

African Journal <strong>of</strong> Medicine and Medical Sciences. 2001, 30:119-121.<br />

13. Aisien AO, Mutihir JT, Ujah IAO, <strong>Sagay</strong> AS, Imade GE. Fifteen years analysis <strong>of</strong><br />

complications following minilaparotomy female sterilization in <strong>Jos</strong>, Nigeria.<br />

The Nigerian Postgraduate Medical Journal, September 2002; 9 (3):118-122.<br />

14. Otubu JAM, Towobola AO, Aisien AO, Ogunkeye OO. Effects <strong>of</strong> Norplant®<br />

contraceptive subdermal implants on serum lipids and lipoproteins.<br />

Contraception 1993; 47: 149-159.<br />

15. <strong>Sagay</strong> AS, Okeahialam BO, Imade GE. Electrocardiographic changes in Norplant<br />

users in Nigeria. West African Journal <strong>of</strong> Medicine. 2002, 21 (2):146 -148.<br />

16. Okeahialam BN, <strong>Sagay</strong> AS, Imade GE. Prolongation <strong>of</strong> electrocardiographic<br />

intervals in women on Norplant contraceptive: what dangers? African Journal<br />

Medicine and Medical Sciences. 2004, 33: 11-13.<br />

17. Aisien AO, <strong>Sagay</strong> AS, Imade GE, Ujah IAO, Nnana OU. Evaluation <strong>of</strong> Menstrual and<br />

Haematological Parameters after 36 Months <strong>of</strong> Norplant R Contraception. Journal<br />

<strong>of</strong> Obstetrics and Gynaecology 2002; 22(4):406-410.<br />

18. <strong>Sagay</strong> AS, Okeahialam BN, Imade GE , Aisien AO. Evaluation <strong>of</strong> Cardiovascular<br />

Morbidity in Nigerian Women after 3 Years <strong>of</strong> Norplant ® Contraception. African<br />

Journal <strong>of</strong> Reproductive Health, 2008, 12(1):47-53.<br />

19. <strong>Sagay</strong> AS, Imade GE, Aisien AO, Ujah IAO, Muazu MI. Glucose Metabolism in<br />

Norplant users in Northern Nigeria. Contraception. 2000, 62:19-22.<br />

20. VanderJagt DJ, <strong>Sagay</strong> AS, Farmer SE, Imade GE, Glew RH. Effect <strong>of</strong> Norplant<br />

Contraceptive on the Bones <strong>of</strong> Nigerian Women as assessed by Qualitative<br />

Ultrasound and Serum Markers <strong>of</strong> Bone Turnover. Contraception. 2005;72(3):<br />

212-6.<br />

21. Wall LL. Dead mothers and injured wives: the social context <strong>of</strong> maternal morbidity<br />

and mortality among the Hausa <strong>of</strong> northern Nigeria. Stud Fam Plann. 1998<br />

Dec;29(4):341-59.<br />

27


22. Kuti O, Dare FO, Ogunniyi SO. The role <strong>of</strong> referring centres in the tragedy <strong>of</strong><br />

unbooked patients. Trop J Obstet Gynaecol, 2001; 18: 24-26.<br />

23. <strong>Sagay</strong> AS, Ekwempu CC, Kabiru M , Daru PH, Aisien AO. Audit <strong>of</strong> Antenatal Care<br />

in Primary Healthcare Centres (PHCs) In <strong>Jos</strong>, Nigeria. Tropical Journal <strong>of</strong> Obstetrics<br />

and Gynaecology, 2005; 22(2): 147-51.<br />

24. 2008 Nigeria Demographic and Health Survey. National Population Commission,<br />

Abuja. 2010<br />

25. Ujah IAO, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. Factors<br />

contributing to maternal mortality in North-Central Nigeria: a seventeen-year review.<br />

African Journal <strong>of</strong> Reproductive Health Vol. 9(3) 2005: 27-40.<br />

26. Ref 2. South Africa Every Death Counts Writing Group, Bradshaw D, Chopra M,<br />

Kerber K, Lawn JE, Bamford L, Moodley J, Pattinson R, Patrick M, Stephen C,<br />

Velaphi S. Every death counts: use <strong>of</strong> mortality audit data for decision making to save<br />

the lives <strong>of</strong> mothers, babies, and children in South Africa. Lancet. 2008 Apr<br />

12;371(9620):1294-304.<br />

27. Mairiga AG, Saleh W. Maternal mortality at the State Specialist Hospital Bauchi,<br />

Northern Nigeria. East Afr Med J. 2009 Jan;86(1):25-30.<br />

28. Kullima AA, Kawuwa MB, Audu BM, Geidam AD, Mairiga AG. Trends in maternal<br />

mortality in a tertiary institution in Northern Nigeria. Annals <strong>of</strong> African Medicine<br />

2009, 8( 4):221-224.<br />

29. Bhutta ZA, Ali S, Cousens S, Ali TM, Haider BA, Rizvi A, Okong P, Bhutta SZ,<br />

Black RE. Alma-Ata: Rebirth and Revision 6 Interventions to address maternal,<br />

newborn, and child survival: what difference can integrated primary health care<br />

strategies make? Lancet. 2008 Sep 13; 372(9642):972-89.<br />

30. Sule SS, Onayade AA. Community-based antenatal and perinatal interventions and<br />

newborn survival. Niger J Med. 2006 Apr-Jun; 15(2):108-14.<br />

31. <strong>Sagay</strong> A.S., Imade G.E., Nwokedi E.E. HIV Infection in Pregnant Women in Nigeria.<br />

International Journal <strong>of</strong> Obstetrics and Gynaecology. 1999, 66(2):183-184.<br />

32. Massad LS, Riester KA, Anastos KM, et al Prevalence and predictors <strong>of</strong> squamous<br />

cell abnormalities in Papanicolaou smears from women with HIV I. J Acquir Immune<br />

Defic Syndr hum Retrovirol .1999.21:33-41.<br />

33. Schafer A, Friedman W, Mieke M, Schwartiander B, Koch MA. The increased<br />

frequency <strong>of</strong> cervical dysplasia-neoplasia in women infected with the human<br />

immunodeficiency virus is related to degree <strong>of</strong> immunosuppression. Am J Obstet<br />

Gynecol. 1991; 164:593-599.<br />

28


34. <strong>Sagay</strong> AS, Adisa OJ, Ekwempu CC, Saban S, Ford RW. Prevalence <strong>of</strong> Cervical<br />

Intraepithelial Neoplasia in Different HIV Settings in <strong>Jos</strong>, North-Central Nigeria<br />

Journal <strong>of</strong> Medicine in the Tropics . 2008; 10(2): 41-48.<br />

35. <strong>Sagay</strong> AS, Imade GE, Egah DZ, Onwuliri VA, Adisa J, Grigg MJ, Musa J, Thacher<br />

TD, Potts M, Short R. Genital Tract Abnormalities among Female Sex Workers Who<br />

Douche With Lemon/Lime Juice in Northern Nigeria. African Journal <strong>of</strong><br />

Reproductive Health. 2009; 13(1): 49-57.<br />

36. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial<br />

<strong>of</strong> nevirapine versus a combination <strong>of</strong> zidovudine and lamivudine to reduce<br />

intrapartum and early postpartum MTCT <strong>of</strong> HIV-1. J infect Dis 2003; 167: 725-735.<br />

37. <strong>Sagay</strong> AS, Musa J, Adewole AS, Imade GE, Ekwempu CC, Kapiga SH, Sankale JL,<br />

Idoko JA, Kanki P. Rapid HIV Testing And Counselling In Labour In A Northern<br />

Nigerian Setting. African Journal <strong>of</strong> Reproductive Health. 2006 10(1): 76-80.<br />

38. <strong>Sagay</strong> AS, Onakewhor J, Galadanci H, Emuveyan EE. HIV Status <strong>of</strong> Partners <strong>of</strong> HIV<br />

Positive Pregnant Women in Different Regions <strong>of</strong> Nigeria: Matters Arising. African<br />

Journal Medicine and Medical Sciences, 2006 35, Suppl.: 125-129.<br />

39. John C. Caldwell. Understanding the AIDS Epidemic and Reacting Sensibly To It.<br />

Social Science and Medicine. 1995; 41 (3): 299-302.<br />

40. Way P. O. and Stanecki K. Focusing <strong>of</strong> HIV/AIDS. In Worm Population Pr<strong>of</strong>ile:<br />

1994 (Edited by Jamison E. and Hobbs F.), p. 50. Bureau <strong>of</strong> the Census, Washington<br />

DC, 1994.<br />

41. <strong>Sagay</strong> AS, Musa J, Ekwempu CC, Imade GE, Babalola A, Daniyan G, Malu N, Idoko<br />

JA, Kanki P. Partner Disclosure <strong>of</strong> HIV Status among HIV Positive Mothers in<br />

Northern Nigeria. African Journal Medicine and Medical Sciences, 2006 35, Suppl.:<br />

119-123.<br />

29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!